Laser treatment of infantile hemangioma

J Cosmet Dermatol. 2023 Jun:22 Suppl 2:1-7. doi: 10.1111/jocd.15671. Epub 2023 Feb 12.

Abstract

Back grounds and objective: Infantile hemangiomas (IH) are common benign tumors of infancy. Most IH either involute spontaneously or respond to treatment with systemic Beta- blockers, but unfortunately not in all cases. In poor responses or in cases of contra indications for pharmacological treatment, laser treatment poses a very good solution.

Methods: As a search strategy and study selection we searched the MEDLINE database via PubMed starting 1982 to June 2022 using a key terms related to interventions for IH (e.g., infantile hemangioma, laser, Beta blockers).

Results: In this article, we reviewed the published data regarding the use of energy-based devices in treatment of children with IH, and noted our experience over the course of treating dozens of cases over the years.

Conclusion: There are many laser systems used for the treatment of hemangioma and vascular tumors. These laser systems are of different wavelengths and penetration depths, however, they operate by similar mechanisms and in some cases two or more lasers can be applied during the course of treating these lesions.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Child
  • Hemangioma* / drug therapy
  • Hemangioma* / radiotherapy
  • Hemangioma* / surgery
  • Humans
  • Infant
  • Lasers, Dye* / therapeutic use
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / radiotherapy
  • Skin Neoplasms* / surgery
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists